Generation of an avian influenza DIVA vaccine with a H3-peptide replacement located at HA2 against both highly and low pathogenic H7N9 virus

References

• Kile JC, Ren R, Liu L, et al. Update: increase in human infections with Novel Asian Lineage Avian Influenza A(H7N9) viruses during the fifth epidemic — China, October 1, 2016–august 7, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(35):928–932. DOI:10.15585/mmwr.mm6635a2
   PubMed Web of Science ®Google Scholar
• Su S, Gu M, Liu D, et al. Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China. Trends Microbiol. 2017;25(9):713–728. DOI:10.1016/j.tim.2017.06.008
   PubMed Web of Science ®Google Scholar
• Yu H, Cowling BJ, Feng L, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet. 2013;382:138–145.
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao H, Wu Y, et al. H7N9: a low pathogenic avian influenza A virus infecting humans. Curr Opin Virol. 2014;5:91–97.
   PubMed Web of Science ®Google Scholar
• Shi J, Deng G, Kong H, et al. H7N9 virulent mutants detected in chickens in China pose an increased threat to humans. Cell Res. 2017;27(12):1409–1421. DOI:10.1038/cr.2017.129
   PubMed Web of Science ®Google Scholar
• Zeng X, Tian G, Shi J et al. Vaccination of poultry successfully eliminated human infection with H7N9 virus in China. Sci China Life Sci. 2018;61(12):1465–1473.
   PubMed Web of Science ®Google Scholar
• Li C, Chen H. H7N9 influenza virus in China. Cold Spring Harb Perspect Med. 2021;11(8):a038349.
   Web of Science ®Google Scholar
• Chen H. Avian influenza vaccination: the experience in China. Rev Sci Tech. 2009;28(1):267–274.
   PubMed Web of Science ®Google Scholar
• Iwasenko JM, Cretikos M, Paterson DL, et al. Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza. Clin Infect Dis. 2010;51(1):70–72. DOI:10.1086/653610
   PubMed Web of Science ®Google Scholar
• Papenburg J, Baz M, Hamelin M, et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis. 2010;51(9):1033–1041. DOI:10.1086/656582
   PubMed Web of Science ®Google Scholar
• Klimov A, Balish A, Veguilla V, et al. Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol Biol. 2012;865:25–51.
   PubMedGoogle Scholar
• Laurie KL, Huston P, Riley S, et al. Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting. Influenza Other Respir Viruses. 2013;7(2):211–224. DOI:10.1111/j.1750-2659.2012.0370a.x
   PubMed Web of Science ®Google Scholar
• An TQ, Peng JM, Tian ZJ, et al. Pseudorabies virus variant in Bartha-K61–vaccinated Pigs, China, 2012. Emerg Infect Dis. 2013;19(11):1749–1755. DOI:10.3201/eid1911.130177
   PubMed Web of Science ®Google Scholar
• Gu Z, Dong J, Wang J, et al. A novel inactivated gE/gi deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge. Virus Res. 2015;195:57–63.
   PubMed Web of Science ®Google Scholar
• Yu X, Zhou Z, Hu D, et al. Pathogenic pseudorabies virus, China, 2012. Emerg Infect Dis. 2014;20(1):102–104. DOI:10.3201/eid2001.130531
   PubMed Web of Science ®Google Scholar
• Ozaki H, Sugiura T, Sugita S et al. Detection of antibodies to the nonstructural protein (NS1) of influenza a virus allows distinction between vaccinated and infected horses. Vet Microbiol. 2001;82(2):111–119.
   PubMed Web of Science ®Google Scholar
• Capua I, Terregino C, Cattoli G et al. Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol. 2003;32(1):47–55.
   PubMed Web of Science ®Google Scholar
• Kim SM, Kim YI, Park SJ, et al. Vaccine efficacy of inactivated, chimeric hemagglutinin H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy. Journal of Virology. 2017;91(6) :e01693–16.
   Web of Science ®Google Scholar
• Sun Z, Wang Q, Li G, et al. Development of an inactivated H7N9 subtype avian influenza serological DIVA vaccine using the chimeric HA epitope approach. Microbiol Spectr. 2021;9(2):e0068721. DOI:10.1128/Spectrum.00687-21
   PubMed Web of Science ®Google Scholar
• Phipps LP, Essen SC, Brown IH. Genetic subtyping of influenza a viruses using RT-PCR with a single set of primers based on conserved sequences within the HA2 coding region. J Virol Methods. 2004;122(1):119–122.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhu Y, Yang D, et al. Efficacy of live-attenuated H9N2 influenza vaccine candidates containing NS1 truncations against H9N2 avian influenza viruses. Front Microbiol. 2017;8:1086.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Z, Su X, et al. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine. Vaccine. 2019;37(13):1736–1742. DOI:10.1016/j.vaccine.2019.02.012
   PubMed Web of Science ®Google Scholar
• Hoffmann E, Neumann G, Kawaoka Y et al. A DNA transfection system for generation of influenza a virus from eight plasmids. Proc Natl Acad Sci U S A. 2000;97(11):6108–6113.
   PubMed Web of Science ®Google Scholar
• Mo IP, Brugh M, Fletcher OJ et al. Comparative pathology of chickens experimentally inoculated with avian influenza viruses of low and high pathogenicity. Avian Dis. 1997;41(1):125–136.
   PubMed Web of Science ®Google Scholar
• Ling S, Pang J, Yu J, et al. Preparation and identification of monoclonal antibody against fumonisin B(1) and development of detection by Ic-ELISA. Toxicon. 2014;80:64–72.
   PubMed Web of Science ®Google Scholar
• Ling S, Wang R, Gu X, et al. Rapid detection of fumonisin B1 using a colloidal gold immunoassay strip test in corn samples. Toxicon. 2015;108:210–215.
   PubMed Web of Science ®Google Scholar
• Groopman JD, Trudel LJ, Donahue PR et al. High-Affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. Proc Natl Acad Sci U S A. 1984;81(24):7728–7731.
   PubMed Web of Science ®Google Scholar
• Hashem AM. Prospects of HA-based universal influenza vaccine. Biomed Res Int. 2015;2015:414637.
   PubMed Web of Science ®Google Scholar
• Chiu FF, Venkatesan N, Wu CR, et al. Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Biochem Biophys Res Commun. 2009;383(1):27–31. DOI:10.1016/j.bbrc.2009.03.106
   PubMed Web of Science ®Google Scholar
• Varečková E, Mucha V, Kostolanský F. HA2 glycopolypeptide of influenza A virus and antiviral immunity. Acta Virol. 2013;57:247–256.
   PubMed Web of Science ®Google Scholar
• Sengupta PP, Rudramurthy GR, Ligi M et al. Development and evaluation of recombinant antigen and monoclonal antibody based competition ELISA for the sero- surveillance of surra in animals. J Immunol Methods. 2018;460:87–92.
   PubMed Web of Science ®Google Scholar
• Shi S, Chen S, Han W, et al. Cross-Clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines. Vaccine. 2016;34(3):350–357. DOI:10.1016/j.vaccine.2015.11.045
   PubMed Web of Science ®Google Scholar
• Subbarao K, Chen H, Swayne D, et al. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology. 2003;305(1):192–200. DOI:10.1006/viro.2002.1742
   PubMed Web of Science ®Google Scholar
• Lam TT, Wang J, Shen Y, et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature. 2013;502(7470):241–244. DOI:10.1038/nature12515
   PubMed Web of Science ®Google Scholar
• Wu A, Su C, Wang D, et al. Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe. 2013;14(4):446–452. DOI:10.1016/j.chom.2013.09.001
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yang Y, Liu W, et al. Comparison of biological characteristics of H9N2 avian influenza viruses isolated from different hosts. Arch Virol. 2015;160(4):917–927. DOI:10.1007/s00705-015-2337-y
   PubMed Web of Science ®Google Scholar
• Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 1993;11(9):957–960.
   PubMed Web of Science ®Google Scholar
• Hasan NH, Ignjatovic J, Peaston A et al. Avian influenza virus and DIVA strategies. Viral Immunol. 2016;29(4):198–211.
   PubMed Web of Science ®Google Scholar